Incyte CORP (INCY) — 10-Q Filings

All 10-Q filings from Incyte CORP. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Incyte's Q3 Net Income Soars on Strong Product Sales, R&D Cuts — Oct 28, 2025 Risk: low
Incyte Corporation reported a significant increase in net income for the nine months ended September 30, 2025, reaching $987.371 million, a substantial turnarou
Incyte's Q2 Revenue Jumps 13.3% on Strong Product Sales — Jul 29, 2025 Risk: medium
Incyte Corp reported a significant increase in product revenue for the second quarter of 2025, reaching $775.0 million, up from $700.0 million in the second qua
Incyte Corp Q1 2025 10-Q Filed — Apr 29, 2025 Risk: medium
Incyte Corporation filed its 10-Q for the period ending March 31, 2025. The filing details financial performance for the first quarter of 2025, including revenu
Incyte Corp Q3 2024 10-Q Filing — Oct 29, 2024 Risk: medium
Incyte Corporation filed its 10-Q for the period ending September 30, 2024. The company reported revenue from product sales and royalties, with specific figures
Incyte Corp Q2 2024 10-Q Filing — Jul 30, 2024 Risk: medium
Incyte Corporation filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first half of the y
Incyte Corp. Files 10-Q for Period Ending March 31, 2024 — Apr 30, 2024 Risk: medium
INCYTE CORP (INCY) filed a Quarterly Report (10-Q) with the SEC on April 30, 2024. Incyte Corp. reported financial results for the quarter ended March 31, 2024.

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX